August Krogh mini symposium in Copenhagen

Danish Diabetes Academy is co-financing the August Krogh mini symposium on 19 May 2017 in Copenhagen featuring Professor Hadi Al-Hasani and Dr. Adam J. Rose from Germany, and Dr. Benjamin L. Parker and Professor Mark A Febbraio from Australia. All interested researchers are invited on behalf of the August Krogh Club steering committee.
TIME AND PLACE
19 May 2017, 13:00-17:00
Auditorium 1, August Krogh Building
Universitetsparken 13, DK-2100 Copenhagen
PROGRAMME
13:00-13:55 | Professor Hadi Al-Hasani, Dissecting the pathophysiology and genetics of type 2 diabetes and obesity with polygenic mouse models |
13:55-14:25 | Dr. Benjamin L. Parker, Genetic Regulation of Proteome and Lipidome Diversity and its Contribution to Hepatic Steatosis |
14:25-14:30 | Short break |
14:30-15:00 | Dr. Adam J. Rose, Liver adaptive stress signalling and systemic metabolic control |
15:00-15:55 | Professor Mark A Febbraio, The engineered designer cytokine IC7 protects against obesity-induced metabolic disease |
16:00-17:00 | Reception |
REGISTRATION
Participation is free, but please register here.
PhD students participating in August Krogh seminars receive 0,2 ECTS per seminar.
DISSECTING THE PATHOPHYSIOLOGY AND GENETICS OF TYPE 2 DIABETES AND OBESITY WITH POLYGENIC MOUSE MODELS
v/ Professor Hadi Al-Hasani, Director, Institute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Leibniz-Center for Diabetes Research at the Heinrich-Heine-University, Düsseldorf, Germany.
Research interests have been identifying and characterizing susceptibility genes and patho-mechanisms for insulin resistance and type 2 diabetes by using experimental mouse genetics, and investigating insulin action, in particular glucose uptake and metabolism in adipose cells and skeletal muscle. Recently, his group has established a critical role of RabGAPs in both insulin- and contraction-induced glucose uptake in skeletal muscle, and the respective mechanisms are being further investigated in vivo and in vitro using biochemical and cell biology methods.
GENETIC REGULATION OF PROTEOME AND LIPIDOME DIVERSITY AND ITS CONTRIBUTION TO HEPATIC STEATOSIS
v/ Dr. Benjamin L. Parker, PhD, NHMRC Early Career Fellow, Metabolic Systems Biology Group, Charles Perkins Centre, School of Life and Environmental Science, The University of Sydney, Australia.
Dr Parker completed his PhD with A/Prof. Stuart Cordwell and Prof. Martin Larsen between the University of Sydney and the University of Southern Denmark developing proteomic and mass spectrometry (MS) assays applied to study signal transduction and metabolism during ischemia. He was the receipt of multiple awards most notably the European Proteomics Association (EuPA) Young Investigator of the Year Award (2010) and the Royal Society of NSW Award (2011).
LIVER ADAPTIVE STRESS SIGNALLING AND SYSTEMIC METABOLIC CONTROL
v/ Dr. Adam J. Rose, PhD, Molecular Metabolic Control, German Cancer Research Center, Heidelberg, Germany.
Dr. Adam J. Rose completed his PhD at Deakin University, Melbourne and then his first Post-Doctoral fellowship at Copenhagen University, Denmark, while studying the role of calcium signalling processes in skeletal muscle metabolism and exercise-adaptation. Afterwards, he took on a posting as a senior scientist, and subsequently as sub-group leader, at the Molecular Metabolic Control Department, German Cancer Research Center, Heidelberg, Germany, where he studies the role of liver stress-signalling pathways in adaptive metabolic control.
THE ENGINEERED DESIGNER CYTOKINE IC7 PROTECTS AGAINST OBESITY-INDUCED METABOLIC DISEASE
v/ Professor PhD, Mark A Febbraio, NHMRC Senior Principal Research Fellow, Head of Division of Diabetes & Metabolism, Head, Cellular & Molecular Metabolism Laboratory, Garvan Institute of Medical Research,The Garvan Institute of Medical Research, Sydney Australia.
His research is focussed on understanding cellular and molecular mechanisms associated obesity, inflammation, and related diseases such as type 2 diabetes and cancer and his research is geared towards developing novel drugs to treat such diseases. He has authored over 220 peer reviewed papers in leading journals and has over 20,000 career citations. He has won prizes at international, national and institutional levels. Professor Febbraio is also dedicated to health and fitness and continues to compete in multi-sport endurance events.
FURTHER INFORMATION
For abstracts, relevant publications and more details on the symposium:
- Go to: akc.ku.dk/calendar/2017/
- Contact Jonas Møller Kristensen: jmkristensen@nexs.ku.dk, mobile +45 6092 1309